[
  {
    "date": "2022-12-30",
    "symbol": "CWBR",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 5930731,
    "shortterminvestments": 9806591,
    "vendorreceivable": 27500,
    "prepaidexpenseandotherassetscurrent": 453681,
    "assetscurrent": 16218503,
    "propertyplantandequipmentnet": 65509,
    "otherintangibleassetsnet": 18083,
    "otherassetsnoncurrent": 63572,
    "assets": 16365667,
    "accountspayablecurrent": 180104,
    "accruedliabilitiescurrent": 327868,
    "accountspayableandotheraccruedliabilitiescurrent": 525666,
    "liabilities": 1033638,
    "commonstockvalue": 2907,
    "additionalpaidincapital": 112238392,
    "retainedearningsaccumulateddeficit": -96909270,
    "stockholdersequity": -96909270,
    "liabilitiesandstockholdersequity": 16365667,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 12000000,
    "commonstocksharesissued": 2906926,
    "commonstocksharesoutstanding": 2906926,
    "researchanddevelopmentexpense": 5935718,
    "generalandadministrativeexpense": 6452579,
    "operatingexpenses": 12388297,
    "operatingincomeloss": -12388297,
    "interestincomeexpensenet": 223291,
    "interestexpenseother": 1479,
    "investmentincomenetamortizationofdiscountandpremium": -8723,
    "nonoperatingincomeexpense": 213089,
    "netincomeloss": -12175208,
    "earningspersharebasic": -4.2,
    "weightedaveragenumberofsharesoutstandingbasic": 2900202,
    "earningspersharediluted": -4.2,
    "weightedaveragenumberofdilutedsharesoutstanding": 2900202,
    "sharesoutstanding": 2906926,
    "stockissuedduringperiodvaluesharebasedcompensation": 1663911,
    "payoutforfractionalsharesretiredasaresultofreversestocksplit": -68,
    "stockissuedduringperiodsharesreversestocksplits": -16,
    "stockissuedduringperiodvalueissuedforservices": 25025,
    "stockissuedduringperiodsharesemployeebenefitplan": 5604,
    "saleofcommonstockinatmnet": 210542,
    "saleofcommonstocksinatmnet": 23353,
    "stockholdersequityreversestocksplit": "1:30",
    "depreciationandamortization": 99247,
    "gainlossondispositionofassets": 6449,
    "sharebasedcompensation": 1582205,
    "amortizationofdebtdiscountpremium": 8350,
    "amortizationoffinancingcosts": 373,
    "discountoninvestments": 32275,
    "vendorreceviables": -145999,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -73699,
    "increasedecreaseinaccountspayable": -191889,
    "increasedecreaseinaccruedliabilities": 131848,
    "increasedecreaseinemployeerelatedliabilities": -228648,
    "netcashprovidedbyusedinoperatingactivities": -10446492,
    "proceedsfromsaleofpropertyplantandequipment": 103531,
    "paymentforsecuritydeposit": -6048,
    "paymentstoacquireinvestments": 56650000,
    "proceedsfromredemptionsofinvestments": 68065000,
    "netcashprovidedbyusedininvestingactivities": 11524579,
    "proceedsfromstockplans": 25025,
    "proceedsfromtheatthemarketofferingnet": 216393,
    "paymentsofstockissuancecosts": 5851,
    "proceedsfromrepaymentsofrelatedpartydebt": -375000,
    "reversestocksplitfractionalsharepayout": -68,
    "netcashprovidedbyusedinfinancingactivities": -139501,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 938586,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 5930731,
    "incometaxespaid": 1332,
    "interestpaidnet": 114411,
    "liquidityandmanagementsplantextblock": "Note 2 – Liquidityand Management’s Plans  ",
    "commonstockpurchasewarrantspolicytextblock": "CommonStock Purchase Warrants  ",
    "scheduleofincometaxprovisionconsiststabletextblock": "            For the Years Ended December 31,             2022      2021       Federal                    Current     $-      $-       Deferred      (1,909,246)      (2,723,112)      State and local                      Current      -       -       Deferred      (641,044)      (905,577)      Change in valuation allowance      2,550,290       3,628,689       Income tax provision (benefit)     $-      $-    ",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.03055,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.92,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1496026,
    "totalpropertyandequipment": 72064,
    "propertyplantandequipmentgross": 484805,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 419296,
    "finitelivedintangibleassetsgross": 23963,
    "amortization": -5880,
    "intangibleassetsnetincludinggoodwill": 18083,
    "labservicessupplies": 160482,
    "accruedprofessionalfeescurrent": 167386,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 133591,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 354274,
    "deferredtaxassetsoperatinglosscarryforwards": 20980803,
    "deferredtaxassetsinprocessresearchanddevelopment": 1340317,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 1419818,
    "deferredtaxassetsgross": 24228803,
    "deferredtaxassetsnet": 24228803,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.071,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.001,
    "effectiveincometaxratereconciliationprioryearincometaxes": 0.109,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.037000000000000005,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.21,
    "deferredfederalincometaxexpensebenefit": -1909246,
    "deferredstateandlocalincometaxexpensebenefit": -641044,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 2550290,
    "sellinggeneralandadministrativeexpense": 1663911,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 317857,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 194853,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 45.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 38.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 38.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 6.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptiongrantsinperiodgross": 19367,
    "sharebasedcompensationsarrangementbysharesbasedpaymentawardoptionsexercisablegranted.": 694,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexercisepricegranted": 10.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantinperiodweightedaveragegrantdatefairvalue": 4.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionscontractuallifeyears": 6.27,
    "stockoptionsoutstansharebasedcompensationarrangementbysharebasedpaymentawardoptionforfeituresandexpirationsinperioddingcancelledinshare": 67921,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 159,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 265.8,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 172.14,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 317857,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 194853,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": 5.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 1178169,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionexercisablenumber": 1178169,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexerciseprice": 30.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexercisepriceexercisablebalance": 30.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprices": 17.83,
    "weightedaveragecontractuallifeyearsendingbalance": 3.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionforfeituresandexpirationsinperiod": 9634,
    "otherdepreciationandamortization": 99247,
    "othercostandexpenseoperating": 1763158,
    "amortizationoffinancingcostsanddiscounts": 8350,
    "otherexpenses": 8350,
    "totalnoncashexpenses": 1771508,
    "investmentsandcash": 15700000,
    "workingcapital": 15200000,
    "stockholdersequityother": 15300000,
    "incomelossfromequitymethodinvestments": 12200000,
    "usgovernmentsecuritiesatcarryingvalue": 9800000,
    "cashequivalentsatcarryingvalue": 3900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4200000,
    "gainlossonsaleofpropertyplantequipment": 6000,
    "saleleasebacktransactionnetbookvalue": 100000,
    "sellingexpense": 100000,
    "depreciationexpenseonreclassifiedassets": 100000,
    "amortizationexpenseperdollarofgrossrevenue": 1226,
    "finitelivedintangibleassetsamortizationexpenserollingyearfive": 1226,
    "amortizationofintangibleassets": 12000,
    "debtinstrumentfaceamount": 400000,
    "debtinterestamount": 100000,
    "paymentsaggregating": 765000,
    "percentageofpaymentsforadditionalproductsdevelopedandsold": 0.5,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 80000,
    "administrativefeesexpense": 50000,
    "percentageofworldwidenetsales": 0.02,
    "royaltyexpense": 75000,
    "royaltydescription": "The Company is required to pay the Regents royalties rangingfrom 8% of worldwide sublicense sales of covered products (if the sublicense is entered after commencement of Phase II clinical trials)to 12% of worldwide sublicense sales (if the sublicense is entered prior to commencement of Phase I clinical trials).",
    "directtaxesandlicensescosts": 10000,
    "costmaintenance": 7500,
    "maintenancefees": 5000,
    "paymentsforrent": 400000,
    "deferredtaxassetsvaluationallowance": 2600000,
    "operatinglosscarryforwards": 74800000,
    "taxcreditcarryforwardamount": 1300000,
    "netamountatriskbyproductandguaranteeguaranteedminimumreturnrate": 0.15,
    "averagetermofcreditriskderivatives1": 3,
    "additionalliabilitylongdurationinsuranceinterestincomeexpense": 1000000000,
    "effectiveincometaxratereconciliationbeatpercent": 0.01,
    "issuanceandsaleofstock": 23400,
    "excessstocksharesauthorized": 12000000,
    "amountofatmavailability": 5000000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "five years",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 21.6,
    "sharesofcommonstockpurchase": 21600,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsoptionsremainingtobeissued": 200000,
    "optionstopurchasecommonstock": 19400,
    "weightedaverageexercisepricegranted": 10.42,
    "stockoptionsterm": "ten years",
    "awardeeoveraperiod": "four years",
    "additionalcollateralaggregatefairvalue": 200000,
    "warrantstopurchasecommonstockexpiredandcancelled": 67900,
    "stockissuedduringperiodsharesstockwarrantsexpired": 9600,
    "percentageofinterestbearingdomesticdepositstodepositsmoneymarket": 0.85,
    "sharesissued": 5600,
    "employeecompensationdeferrals": 25000,
    "stockissuedduringperiodsharesconversionofunits": 10500,
    "entityregistrantname": "COHBAR, INC.",
    "tradingsymbol": "CWBR",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1522602,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38326",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "26-1299952",
    "entityaddressaddressline1": "1455 Adams Drive",
    "entityaddressaddressline2": "Suite 2050",
    "entityaddresscityortown": "Menlo Park",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94025,
    "cityareacode": "(650)",
    "localphonenumber": "446-7888",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 688,
    "auditorname": "Marcum llp",
    "auditorlocation": "New York, NY"
  },
  {
    "date": "2021-12-30",
    "symbol": "CWBR",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 4992145,
    "shortterminvestments": 21253866,
    "vendorreceivable": 173499,
    "prepaidexpenseandotherassetscurrent": 527380,
    "assetscurrent": 26946890,
    "propertyplantandequipmentnet": 260612,
    "otherintangibleassetsnet": 19309,
    "otherassetsnoncurrent": 69620,
    "assets": 27296431,
    "accountspayablecurrent": 371993,
    "accruedliabilitiescurrent": 196020,
    "accountspayableandotheraccruedliabilitiescurrent": 754314,
    "shorttermborrowings": 366277,
    "liabilitiescurrent": 1688604,
    "liabilities": 1688604,
    "commonstockvalue": 86340,
    "additionalpaidincapital": 110255549,
    "retainedearningsaccumulateddeficit": -84734062,
    "stockholdersequity": -84734062,
    "liabilitiesandstockholdersequity": 27296431,
    "debtinstrumentunamortizeddiscountcurrent": 8723,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 180000000,
    "commonstocksharesissued": 86339567,
    "commonstocksharesoutstanding": 86339567,
    "researchanddevelopmentexpense": 7705090,
    "generalandadministrativeexpense": 7703065,
    "operatingexpenses": 15408155,
    "operatingincomeloss": -15408155,
    "interestincomeexpensenet": 5578,
    "interestexpenseother": 40108,
    "investmentincomenetamortizationofdiscountandpremium": -33091,
    "nonoperatingincomeexpense": -67621,
    "netincomeloss": -15475776,
    "earningspersharebasicanddiluted": -0.23,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 66629458,
    "sharesoutstanding": 86339567,
    "stockissuedduringperiodvaluesharebasedcompensation": 2543712,
    "stockissuedduringperiodvalueacquisitions": 16814,
    "stockissuedduringperiodsharesemployeebenefitplan": 17662,
    "stockissuedduringperiodvalueemployeestockownershipplan": 1240490,
    "stockissuedduringperiodsharesemployeestockownershipplan": 1262146,
    "stockissuedduringperiodvalueexerciseofwarrants": 2089476,
    "stockissuedduringperiodsharesexerciseofwarrantsinshares": 1451025,
    "saleofcommonstockinatmnet": 2884786,
    "saleofcommonstocksinatmnet": 1657876,
    "stockissuedduringperiodvalueother": 13821170,
    "stockissuedduringperiodsharesother": 20833334,
    "profitloss": -15475776,
    "depreciationandamortization": 140914,
    "employeebenefitsandsharebasedcompensation": 2543712,
    "amortizationofdebtdiscountpremium": 31687,
    "amortizationoffinancingcosts": 1405,
    "discountoninvestments": -1600,
    "vendorreceviables": 173499,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 113688,
    "increasedecreaseinaccountspayable": -355606,
    "increasedecreaseinaccruedliabilities": -945721,
    "increasedecreaseinemployeerelatedliabilities": -99021,
    "netcashprovidedbyusedinoperatingactivities": -14447193,
    "paymentstoacquirepropertyplantandequipment": 6397,
    "paymentforsecuritydeposit": 2217,
    "paymentstoacquireintangibleassets": 2359,
    "paymentstoacquireinvestments": 43601000,
    "proceedsfromsaleofrestrictedinvestments": 40469000,
    "netcashprovidedbyusedininvestingactivities": -3142973,
    "proceedsfromstockplans": 16814,
    "proceedsfromissuanceinitialpublicoffering": 15000000,
    "costsofpublicoffering": -1178830,
    "proceedsfromtheatthemarketofferingnet": 2980595,
    "costsofatthemarketoffering": -95809,
    "proceedsfromwarrantexercises": 2089476,
    "proceedsfromrepaymentsofrelatedpartydebt": -365000,
    "proceedsfromstockoptionsexercised": 1240490,
    "netcashprovidedbyusedinfinancingactivities": 19687736,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 2097570,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 4992145,
    "incometaxespaid": 1332,
    "interestpaidnet": 89908,
    "liquidityandmanagementsplantextblock": "Note2 – Liquidity and Management’s Plans  ",
    "commonstockpurchasewarrantspolicytextblock": "CommonStock Purchase Warrants  ",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0138,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.92,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 46626410,
    "propertyplantandequipmentgross": 932495,
    "lessaccumulateddepreciation": 671883,
    "finitelivedintangibleassetsgross": 23963,
    "amortization": -4654,
    "intangibleassetsnetincludinggoodwill": 19309,
    "labservicessupplies": 6080,
    "accruedprofessionalfeescurrent": 73090,
    "interestpayablecurrent": 112932,
    "otheraccruedexpenses": 3918,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 144077,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1800762,
    "deferredtaxassetsoperatinglosscarryforwards": 19481137,
    "deferredtaxassetsinprocessresearchanddevelopment": 252536,
    "deferredtaxassetsgross": 21678512,
    "deferredtaxvaluationallowance": 21678512,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.07,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.025,
    "effectiveincometaxratereconciliationprioryearincometaxes": 0.027000000000000003,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.22899999999999998,
    "deferredfederalincometaxexpensebenefit": -2723112,
    "deferredstateandlocalincometaxexpensebenefit": 905577,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 3628689,
    "sharebasedcompensation": 2543712,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 10992335,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 6126901,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 1.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 1.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 36273,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 6314000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablegranted": -1262146,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionexercisablenumber": 35629908,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 1529410,
    "weightedaveragecontractuallifeyearendingbalance": 6.27,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 5.3,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 6.44,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 10992335,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 6126901,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": 6.35,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 8.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 35634075,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexerciseprice": 1.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexercisepriceexercisablebalance": 1.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprices": 0.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalueone": 71737,
    "weightedaveragecontractuallifeyearsendingbalanceofwarrants": 4.38,
    "warrantsoutstandinggrantedinshares": 20893334,
    "stockissuedduringperiodshareswarrantsexercised": 1451025,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionforfeituresandexpirationsinperiod": 3181052,
    "depreciationamortization": 140914,
    "subtotalnoncashoperatingexpenses": 2684626,
    "amortizationofdebtdiscount": 31687,
    "subtotalotherexpense": 31687,
    "operatingcostsandexpenses": 2716313,
    "investmentsandcash": 26200000,
    "workingcapital": 25300000,
    "usgovernmentsecuritiesatcarryingvalue": 21300000,
    "estimatedusefullife": 20,
    "cashequivalentsatcarryingvalue": 700000,
    "propertyplantandequipmentusefullife": "five years",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 6000000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 100000,
    "amortizationexpenseperdollarofgrossrevenue": 1125,
    "finitelivedintangibleassetsamortizationexpenserollingyearfive": 1226,
    "amortizationofintangibleassets": 13184,
    "debtinstrumentinterestratestatedpercentage": 0.08,
    "debtinstrumentfaceamount": 100000,
    "issuedunits": 100000,
    "debtinstrumentconvertibleconversionprice1": 1.22,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 1.44,
    "othernotespayablecurrent": 400000,
    "interestpayablecurrentandnoncurrent": 400000,
    "repaymentsofdebt": 400000,
    "paymentsaggregating": 765000,
    "percentageofpaymentsforadditionalproductsdevelopedandsold": 0.5,
    "costmaintenance": 7500,
    "maintenancefees": 5000,
    "percentageofworldwidenetsales": 0.02,
    "royaltyexpense": 75000,
    "royaltydescription": "The Company is required to pay theRegents royalties ranging from 8% of worldwide sublicense sales of covered products (if the sublicense is entered after commencementof Phase II clinical trials) to 12% of worldwide sublicense sales (if the sublicense is entered prior to commencement of PhaseI clinical trials).",
    "directtaxesandlicensescosts": 10000,
    "paymentsforrent": 0.4,
    "deferredtaxassetsvaluationallowance": 3600000,
    "operatinglosscarryforwards": 70000000,
    "taxcreditcarryforwardlimitationsonuse": "The Company’s 2017and prior federal and state net operating loss carry forwards, if not utilized, will begin to expire from 2029 to 2037. Beginningwith 2018, and for subsequent years, the Company’s NOLs will have indefinite lives for federal tax purposes.",
    "taxcreditcarryforwardamount": 900000,
    "taxcreditcarryforwarddescription": "TheseR&D tax credits will begin to expire from 2033 to 2040, respectively.",
    "issuanceandsaleofstock": 20800000,
    "excessstocksharesauthorized": 180000000,
    "netrealizedundertheatmsales": 2900000,
    "professionalfees": 1200000,
    "amountofatmavailability": 12500000,
    "paymentsforcommissions": 13800000,
    "shareprice": 0.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsoptionsremainingtobeissued": 3.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 6300000,
    "grantdateprices": 1.38,
    "aggregategrantdatefairvalue": 5800000,
    "sharesofcommonstockpurchase": 100000,
    "cashproceeds": 2100000,
    "purchaseshares": 1500000,
    "saleofstockpricepershare": 1.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Fifty thousand of these warrants were valued using the Black-Scholesoption pricing model and the corresponding expense will be recognized over the service period of three years. Ten thousand ofthese warrants were performance based. During the year ended December 31, 2021, the performance criteria were met and the warrantswere valued and expensed at the time the performance conditions were met. The warrants have terms that range from two to threeyears with vesting over a one-year period.",
    "stockissuedduringperiodsharesstockwarrantsexercised": 1500000,
    "warrantstopurchasecommonstockexpiredandcancelled": 3200000,
    "stockissuedduringperiodsharespurchaseofassets": 600000,
    "othercostandexpenseoperating": 500000,
    "presentvalueofcashflowofmodifieddebt": 0.1,
    "percentageofinterestbearingdomesticdepositstodepositsmoneymarket": 0.85,
    "sharesissued": 17662,
    "employeecompensationdeferrals": 16814,
    "stockissuedduringperiodsharesconversionofunits": 482338,
    "descriptiononwarrants": "the Company granted stock optionsto purchase a total of 0.4 million shares of the Company’s common stock with an exercise price of $0.43 per share. The stock optionshave a term of ten years with vesting over a four-year period.",
    "salescommissionsandfees": 200000,
    "repaymentofnotesreceivablefromrelatedparties": 500000,
    "entityregistrantname": "CohBar, Inc.",
    "tradingsymbol": "CWBR",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1522602,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38326",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "26-1299952",
    "entityaddressaddressline1": "1455Adams Drive",
    "entityaddressaddressline2": "Suite 2050",
    "entityaddresscityortown": "MenloPark",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94025,
    "cityareacode": "(650)",
    "localphonenumber": "446-7888",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 688,
    "auditorname": "Marcumllp",
    "auditorlocation": "NewYork, NY"
  },
  {
    "date": "2020-12-30",
    "symbol": "CWBR",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 2894575,
    "shortterminvestments": 18120266,
    "prepaidexpenseandotherassetscurrent": 413692,
    "assetscurrent": 21428533,
    "propertyplantandequipmentnet": 394004,
    "otherintangibleassetsnet": 18075,
    "otherassetsnoncurrent": 67403,
    "assets": 21908015,
    "accountspayablecurrent": 727599,
    "accruedliabilitiescurrent": 1141741,
    "accountspayableandotheraccruedliabilitiescurrent": 853335,
    "shorttermborrowings": 349344,
    "liabilitiescurrent": 3072019,
    "longtermdebt": 348841,
    "liabilities": 3420860,
    "commonstockvalue": 61118,
    "additionalpaidincapital": 87684323,
    "retainedearningsaccumulateddeficit": -69258286,
    "stockholdersequity": -69258286,
    "liabilitiesandstockholdersequity": 21908015,
    "debtinstrumentunamortizeddiscountcurrent": 15656,
    "debtinstrumentunamortizeddiscountnoncurrent": 26159,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 180000000,
    "commonstocksharesissued": 61117524,
    "commonstocksharesoutstanding": 61117524,
    "researchanddevelopmentexpense": 6937610,
    "generalandadministrativeexpense": 6261905,
    "operatingexpenses": 13199515,
    "operatingincomeloss": -13199515,
    "investmentincomeinterest": 41149,
    "interestexpenseother": 311410,
    "debtrelatedcommitmentfeesanddebtissuancecosts": 2290688,
    "investmentincomenetamortizationofdiscountandpremium": -504497,
    "nonoperatingincomeexpense": -3065446,
    "netincomeloss": -16264961,
    "earningspersharebasicanddiluted": -0.33,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 48814353,
    "sharesoutstanding": 61117524,
    "stockgrantedduringperiodvaluesharebasedcompensationgross": 2216316,
    "equitymodificationexpense": 2290688,
    "stockissuedduringperiodvalueemployeestockownershipplan": 252385,
    "stockissuedduringperiodsharesemployeestockownershipplan": 223924,
    "stockissuedduringperiodvalueother": 45000,
    "stockissuedduringperiodsharesother": 20000,
    "saleofcommonstockinatmnet": 4308352,
    "saleofcommonstockinatmnetinshares": 2350067,
    "saleofcommonstockincmponet": 13655531,
    "saleofcommonstockincmponetinshares": 12300000,
    "stockissuedduringperiodvalueconversionofunits": 131000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 3154115,
    "depreciationandamortization": 156664,
    "sharebasedcompensation": 1612209,
    "amortizationofdebtdiscountpremium": 463781,
    "amortizationoffinancingcosts": 40716,
    "discountoninvestments": 2734,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 52381,
    "increasedecreaseinaccountspayable": 282823,
    "increasedecreaseinaccruedliabilities": 909567,
    "increasedecreaseinemployeerelatedliabilities": 175580,
    "netcashprovidedbyusedinoperatingactivities": -9778473,
    "paymentstoacquirepropertyplantandequipment": 25912,
    "paymentsforproceedsfromotherinvestingactivities": 3161,
    "paymentstoacquireinvestments": 25417000,
    "proceedsfromsaleofrestrictedinvestments": 7294000,
    "netcashprovidedbyusedininvestingactivities": -18152073,
    "proceedsfrompublicofferingnet": 13655531,
    "proceedsfromtheatthemarketofferingnet": 4308352,
    "proceedsfromexerciseofwarrants": 45000,
    "proceedsfromstockoptionsexercised": 958847,
    "netcashprovidedbyusedinfinancingactivities": 18261268,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -9669278,
    "conversionofpromissorynotestocommonstock": 3847018,
    "incometaxespaidnet": 1300,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0085,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.97,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 26842709,
    "propertyplantandequipmentgross": 926098,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 532094,
    "finitelivedpatentsgross": 21604,
    "finitelivedintangibleassetsaccumulatedamortization": 3529,
    "finitelivedintangibleassetsnet": 18075,
    "labservicessupplies": 917194,
    "accruedprofessionalfeescurrent": 44171,
    "interestpayablecurrent": 162731,
    "otheraccruedexpenses": 17645,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 464042,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 869815,
    "deferredtaxassetsoperatinglosscarryforwards": 16165927,
    "deferredtaxassetsinprocessresearchanddevelopment": 548983,
    "deferredtaxassetsgross": 18048767,
    "deferredtaxvaluationallowance": 18048767,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.07,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.004,
    "effectiveincometaxratereconciliationprioryearincometaxes": -0.004,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.005,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.285,
    "deferredfederalincometaxexpensebenefit": -3482375,
    "deferredstateandlocalincometaxexpensebenefit": -1158072,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 4640447,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7469891,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5390431,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 1.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 0.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 866300,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 275000,
    "stockissuedduringperiodsharesstockoptionsexercised": 623901,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 213543,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P4Y25D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 5.3,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 8.86,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 6.25,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 7469891,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 5390431,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P7Y124D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 19372818,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionexercisablenumber": 15495973,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexerciseprice": 1.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexercisepriceexercisablebalance": 1.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 14485595,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 46900,
    "depreciationamortization": 156664,
    "subtotalnoncashoperatingexpenses": 2372980,
    "amortizationofdebtdiscount": 504498,
    "employeebenefitsandsharebasedcompensation": 2290688,
    "subtotalotherexpense": 2795186,
    "operatingcostsandexpenses": 5168166,
    "workingcapital": 18356514,
    "fundingfromequityexercises": 1000000,
    "certificatesofdepositatcarryingvalue": 18120266,
    "propertyplantandequipmentestimatedusefullives": "20 years",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 2538211,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiodterm": "approximately four years.",
    "depreciation": 155585,
    "propertyplantandequipmentdisposals": 833,
    "adjustmentforamortization": 1079,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 1079,
    "finitelivedintangibleassetsamortizationexpenserollingafteryearfive": 12680,
    "debtinstrumentinterestrateeffectivepercentage": 0.08,
    "debtinstrumentfaceamount": 3847018,
    "sharesissued": 3154115,
    "sharesissuedpricepershare": 1.22,
    "stockissuedduringperiodsharesconversionofunits": 107000,
    "milestonepayment": 765000,
    "licensereduced": 0.5,
    "costofgoodsandservicessold": 7500,
    "costofservice": 5000,
    "royaltypercentage": 0.02,
    "royaltyexpense": 75000,
    "licensecost": 10000,
    "operatingleasesrentexpensenet": 403449,
    "royaltydescription": "The Company is required to pay the Regents royalties ranging from 8% of worldwide sublicense sales of covered products (if the sublicense is entered after commencement of Phase II clinical trials) to 12% of worldwide sublicense sales (if the sublicense is entered prior to commencement of Phase I clinical trials).",
    "operatinglosscarryforwards": 58000000,
    "taxcreditcarryforwardlimitationsonuse": "The Company&#x2019;s 2017 and prior federal and state net operating loss carry forwards, if not utilized, will begin to expire from 2029 to 2037. Beginning with 2018, and for subsequent years, the Company&#x2019;s NOLs will have indefinite lives for federal tax purposes.",
    "taxcreditcarryforwardamount": 549000,
    "taxcreditcarryforwarddescription": "These R&amp;D tax credits will begin to expire from 2033 to 2040, respectively.",
    "issuanceandsaleofstock": 185000000,
    "excessstocksharesauthorized": 180000000,
    "saleofstocknumberofsharesissuedintransaction": 2350067,
    "proceedsfromissuanceinitialpublicoffering": 4308352,
    "commissionsandprofessionalfees": 1368919,
    "stockissuedduringperiodsharesnewissues": 12300000,
    "warrantsissuedtopurchasecommonstock": 2365595,
    "stockissuedduringperiodvaluenewissues": 13655531,
    "exerciseprice": 1.44,
    "stockissuedduringperiodsharesperiodincreasedecrease": 14000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsoptionsremainingtobeissued": 5129109,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 275000,
    "saleofstockpricepershare": 2.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 486273,
    "percentageofunsecuredpromissorynote": 0.08,
    "othercostandexpenseoperating": 1591233,
    "priceperwarrant": 2,
    "warrantsdescription": "The Company also granted an additional warrant to purchase 0.5 of one share of its common stock, or 1,511,250 shares of common stock in total, per dollar of each participating 2018 Note holder&#x2019;s principal amount of the 2018 Notes with an exercise price of $2.00 per share and an expiration date of March 29, 2026 (the &#x201c;New Warrants&#x201d;).",
    "warrantstopurchasecommonstockexercised": 20000,
    "proceedsfromissuanceofwarrants": 67536,
    "repaymentofnotesreceivablefromrelatedparties": 105000,
    "descriptiononwarrants": "the Company granted warrants to purchase a total of 60,000 shares of the Company&#x2019;s common stock with an exercise price of $1.38 per share. The warrants have terms that range from two to three years with vesting over a one-year period.",
    "entityregistrantname": "CohBar, Inc.",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1522602,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38326",
    "entityincorporationstatecountrycode": "DE",
    "entityinteractivedatacurrent": "Yes"
  },
  {
    "date": "2019-12-30",
    "symbol": "CWBR",
    "period": "FY",
    "entityregistrantname": "CohBar, Inc.",
    "entitycentralindexkey": 1522602,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "DE",
    "entityfilenumber": "001-38326",
    "cashandcashequivalentsatcarryingvalue": 12563853,
    "prepaidexpenseandotherassetscurrent": 361311,
    "assetscurrent": 12925164,
    "propertyplantandequipmentnet": 523677,
    "otherintangibleassetsnet": 19154,
    "otherassetsnoncurrent": 64242,
    "assets": 13532237,
    "accountspayablecurrent": 444776,
    "accruedliabilitiescurrent": 916692,
    "employeerelatedliabilitiescurrent": 677755,
    "liabilitiescurrent": 2039223,
    "longtermdebt": 3356188,
    "liabilities": 5395411,
    "commonstockvalue": 43069,
    "additionalpaidincapital": 61087082,
    "retainedearningsaccumulateddeficit": -52993325,
    "stockholdersequity": -52993325,
    "liabilitiesandstockholdersequity": 13532237,
    "debtinstrumentunamortizeddiscountcurrent": 546312,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 43069418,
    "commonstocksharesoutstanding": 43069418,
    "researchanddevelopmentexpense": 6631928,
    "generalandadministrativeexpense": 5951106,
    "operatingexpenses": 12583034,
    "operatingincomeloss": -12583034,
    "investmentincomeinterest": 290313,
    "interestexpense": 312200,
    "amortizationofdebtdiscountandofferingcosts": 439851,
    "nonoperatingincomeexpense": -461738,
    "netincomeloss": -13044772,
    "earningspersharebasicanddiluted": -0.3,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 42816616,
    "sharesoutstanding": 43069418,
    "stockgrantedduringperiodvaluesharebasedcompensationgross": 2609370,
    "stockissuedduringperiodvalueemployeestockownershipplan": 551669,
    "stockissuedduringperiodsharesemployeestockownershipplan": 441210,
    "stockissuedduringperiodvalueother": 57450,
    "stockissuedduringperiodsharesother": 50000,
    "depreciationandamortization": 147687,
    "sharebasedcompensation": 1694295,
    "amortizationofdebtdiscountpremium": 420341,
    "amortizationoffinancingcosts": 19510,
    "discountoninvestments": 34574,
    "increasedecreaseinprepaidexpensesother": 100681,
    "increasedecreaseinaccountspayable": -697959,
    "increasedecreaseinaccruedliabilities": 564879,
    "increasedecreaseinemployeerelatedliabilities": 10094,
    "netcashprovidedbyusedinoperatingactivities": -10106105,
    "paymentstoacquirepropertyplantandequipment": 149545,
    "paymentsforproceedsfromotherinvestingactivities": 7449,
    "paymentstoacquireinvestments": 40348000,
    "paymentsforproceedsfrominvestments": -56843000,
    "netcashprovidedbyusedininvestingactivities": 16338006,
    "proceedsfromexerciseofinitialpublicofferingwarrants": 57500,
    "proceedsfromstockoptionsexercised": 552110,
    "netcashprovidedbyusedinfinancingactivities": 609610,
    "cashandcashequivalentsperiodincreasedecrease": 6841511,
    "incometaxespaid": 1300,
    "workingcapital": 10885941,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0218,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.77,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7632358,
    "usgovernmentsecuritiesatcarryingvalue": 9505777,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4972057,
    "propertyplantandequipmentusefullife": "P20Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiodterm": "Approximately four years.",
    "classofwarrantorrightoutstanding": 780500,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 5.3,
    "fairvalueadjustmentofwarrants": 1253390,
    "adjustmentforamortization": 1079,
    "propertyplantandequipmentgross": 60384,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 376509,
    "depreciation": 147441,
    "propertyplantandequipmentdisposals": 833,
    "finitelivedpatentsgross": 21604,
    "finitelivedintangibleassetsaccumulatedamortization": 2450,
    "finitelivedintangibleassetsnet": 19154,
    "finitelivedintangibleassetsamortizationexpenserollingafteryearfive": 13759,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 1079,
    "accruedlabservicescurrent": 131176,
    "accruedprofessionalfeescurrent": 57912,
    "accruedconsultantfeescurrent": 3750,
    "interestpayablecurrent": 544199,
    "otheraccruedexpenses": 179655,
    "notespayablecurrent": 3356188,
    "amortizationoffinancingcostsanddiscounts": 765001,
    "operatingleasesrentexpensenet": 350979,
    "milestonepayment": 765000,
    "licensereduced": 0.5,
    "costofgoodsandservicessold": 7500,
    "costofservice": 5000,
    "royaltypercentage": 0.02,
    "royaltyexpense": 75000,
    "royaltydescription": "The Company is required to pay the Regents royalties ranging from 8% of worldwide sublicense sales of covered products (if the sublicense is entered after commencement of phase II clinical trials to 12% of worldwide sublicense sales (if the sublicense is entered prior to commencement of phase I clinical trials).",
    "licensecost": 10000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 223712,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 838753,
    "deferredtaxassetsoperatinglosscarryforwards": 11978595,
    "deferredtaxassetsinprocessresearchanddevelopment": 367261,
    "deferredtaxassetsgross": 13408321,
    "deferredtaxassetsvaluationallowance": 13408321,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.07,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.03,
    "effectiveincometaxratereconciliationprioryearincometaxes": 0.003,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.007,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.254,
    "deferredfederalincometaxexpensebenefit": -2378218,
    "deferredstateandlocalincometaxexpensebenefit": -790882,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 3169100,
    "operatinglosscarryforwards": 43000000,
    "taxcreditcarryforwardlimitationsonuse": "The Company's 2017 and prior federal and state net operating loss carry forwards, if not utilized, will begin to expire from 2029 to 2038. Beginning with 2018, and for subsequent years, the Company's NOLs will have indefinite lives for federal tax purposes.",
    "deferredtaxassetsnet": 9200000,
    "derivativeassetsliabilitiesatfairvaluenet": 6500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7632358,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2779000,
    "stockissuedduringperiodsharesstockoptionsexercised": 441210,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 193714,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4907223,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 1.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2one": "P2Y3M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P1Y6M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1077594,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 5.3,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 8.86,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 6.62,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 693000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 457933,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P8Y4M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 4907223,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 50000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsforfeitures": -6982,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 2779000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsoptionsremainingtobeissued": 1190566,
    "saleofstockpricepershare": 3.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 3471351,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 80000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P10Y",
    "proceedsfromissuanceofwarrants": 57500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 6982,
    "subtotalnoncashoperatingexpenses": 2757890,
    "operatingcostsandexpenses": 3178231,
    "grantedtostockoptionspurchase": 125000,
    "investmentsoptionexerciseprice": 2.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "The stock options have terms of ten years and are subject to vesting based over a four-year period.",
    "stockoptionsandexercised": 71981,
    "stockissuedduringperiodvaluestockoptionsexercised": 42226,
    "debtinstrumentmaturitydatedescription": "The Company extended the maturity date of the Notes it issued during the year ended December 31, 2018 (see Note 7 - Notes Payable). The original maturity date of March 29, 2021 was extended to June 30, 2021. The expiration date of the warrants that were issued in connection with the Notes was extended from March 29, 2021 to March 29, 2022..",
    "warrantstopurchasesharesofcommonstock": 1200000,
    "debtinstrumentexpirationdatedescription": "The original expiration date of the warrants, June 30, 2020, was extended to September 30, 2021."
  },
  {
    "date": "2018-12-30",
    "symbol": "CWBR",
    "period": "FY",
    "entityregistrantname": "CohBar, Inc.",
    "entitycentralindexkey": 1522602,
    "tradingsymbol": "CWBR",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2018-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2018,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "cashandcashequivalentsatcarryingvalue": 5722342,
    "shortterminvestments": 16460426,
    "prepaidexpenseandotherassetscurrent": 260630,
    "assetscurrent": 22443398,
    "propertyplantandequipmentnet": 520740,
    "otherintangibleassetsnet": 20233,
    "otherassetsnoncurrent": 56793,
    "assets": 23041164,
    "accountspayablecurrent": 1142735,
    "accruedliabilitiescurrent": 351813,
    "employeerelatedliabilitiescurrent": 667661,
    "liabilitiescurrent": 2162209,
    "longtermdebt": 2916337,
    "liabilities": 5078546,
    "commonstockvalue": 42578,
    "additionalpaidincapital": 57868593,
    "retainedearningsaccumulateddeficit": -39948553,
    "stockholdersequity": -39948553,
    "liabilitiesandstockholdersequity": 23041164,
    "debtinstrumentunamortizeddiscountcurrent": 986163,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 75000000,
    "commonstocksharesissued": 42578208,
    "commonstocksharesoutstanding": 42578208,
    "researchanddevelopmentexpense": 10034613,
    "generalandadministrativeexpense": 5299717,
    "operatingexpenses": 15334330,
    "operatingincomeloss": -15334330,
    "investmentincomeinterest": 185614,
    "interestexpense": 231999,
    "amortizationofdebtdiscountandofferingcosts": 325150,
    "nonoperatingincomeexpense": -371535,
    "netincomeloss": -15705865,
    "earningspersharebasicanddiluted": -0.38,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 41254411,
    "sharesoutstanding": 42578208,
    "stockgrantedduringperiodvaluesharebasedcompensationgross": 4318993,
    "stockissuedduringperiodvalueissuedforservices": 19397672,
    "stockissuedduringperiodsharesnewissues": 2186855,
    "adjustmentstoadditionalpaidincapitalofferingcosts": 95778,
    "adjustmentstoadditionalpaidincapitalother": 1253390,
    "stockissuedduringperiodvalueemployeestockownershipplan": 494264,
    "stockissuedduringperiodsharesemployeestockownershipplan": 602533,
    "stockissuedduringperiodvalueother": 677891,
    "stockissuedduringperiodsharesother": 349315,
    "depreciationandamortization": 79128,
    "gainlossonsaleofpropertyplantequipment": -1084,
    "sharebasedcompensation": 1735742,
    "amortizationofdebtdiscountpremium": 311125,
    "amortizationoffinancingcosts": 14025,
    "discountoninvestments": -29583,
    "increasedecreaseinprepaidexpensesother": 96356,
    "increasedecreaseinaccountspayable": 650720,
    "increasedecreaseinaccruedliabilities": 102655,
    "increasedecreaseinemployeerelatedliabilities": 164528,
    "netcashprovidedbyusedinoperatingactivities": -10130380,
    "paymentstoacquirepropertyplantandequipment": 423342,
    "patentcosts": -1739,
    "paymentsforproceedsfromotherinvestingactivities": 9889,
    "paymentstoacquireinvestments": 41402000,
    "paymentsforproceedsfrominvestments": -30541000,
    "netcashprovidedbyusedininvestingactivities": -11292492,
    "proceedsfromrepaymentsofnotespayable": 3902500,
    "paymentsofdebtissuancecosts": 57923,
    "proceedsfromissuanceinitialpublicoffering": 19304081,
    "proceedsfromexerciseofinitialpublicofferingwarrants": 678240,
    "proceedsfromstockoptionsexercised": 494866,
    "netcashprovidedbyusedinfinancingactivities": 24321764,
    "cashandcashequivalentsperiodincreasedecrease": 2898892,
    "warrantsissuedinconnectionwithnotepayable": 1253390,
    "incometaxespaid": 1508,
    "investmentsandcash": 22182768,
    "workingcapital": 20281189,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0251,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.6889,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5488282,
    "financialinstrumentsownedusgovernmentandagencyobligationsatfairvalue": 14339630,
    "certificatesofdepositatcarryingvalue": 2120796,
    "adjustmentforamortization": 1079,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4103258,
    "propertyplantandequipmentusefullife": "P20Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P10Y",
    "propertyplantandequipmentgross": 23191,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 229901,
    "depreciation": 78049,
    "finitelivedpatentsgross": 21604,
    "finitelivedintangibleassetsaccumulatedamortization": 1371,
    "finitelivedintangibleassetsnet": 20233,
    "accruedlabservicescurrent": 7786,
    "accruedprofessionalfeescurrent": 106478,
    "accruedconsultantfeescurrent": 3750,
    "interestpayablecurrent": 231999,
    "otheraccruedexpenses": 1800,
    "debtinstrumentinterestrateeffectivepercentage": 0.08,
    "debtinstrumentfaceamount": 3902500,
    "notespayable": 532500,
    "fairvalueadjustmentofwarrants": 1253390,
    "notespayablecurrent": 2916337,
    "classofwarrantorrightoutstanding": 780500,
    "operatingleasesrentexpensenet": 298972,
    "milestonepayment": 765000,
    "licensereduced": 0.5,
    "costofgoodsandservicessold": 7500,
    "costofservice": 5000,
    "royaltypercentage": 0.02,
    "royaltyexpense": 75000,
    "royaltydescription": "The Company is required to pay the Regents royalties ranging from 8% of worldwide sublicense sales of covered products (if the sublicense is entered after commencement of phase II clinical trials to 12% of worldwide sublicense sales (if the sublicense is entered prior to commencement of phase I clinical trials).",
    "licensecost": 10000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 168068,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 632254,
    "deferredtaxassetsoperatinglosscarryforwards": 8949957,
    "deferredtaxassetsinprocessresearchanddevelopment": 488942,
    "deferredtaxassetsgross": 10239221,
    "deferredtaxassetsvaluationallowance": 10239221,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.07,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.054,
    "effectiveincometaxratereconciliationprioryearincometaxes": 0.002,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.005,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.229,
    "deferredfederalincometaxexpensebenefit": -2837776,
    "deferredstateandlocalincometaxexpensebenefit": -943709,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 3781485,
    "operatinglosscarryforwards": 32000000,
    "taxcreditcarryforwardlimitationsonuse": "The Company's 2017 and prior federal and state net operating loss carry forwards, if not utilized, will begin to expire from 2029 to 2038. Beginning with 2018, and for subsequent years, the Company's NOLs will have indefinite lives for federal tax purposes.",
    "otherinformationpertainingtoincometaxes": "The Company’s gross deferred tax assets have been revalued from 34% to 21% with a corresponding offset to the valuation allowance and any potential other taxes arising due to the Tax Act will result in reductions to its net operating loss carryforward and valuation allowance.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5488282,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 860000,
    "stockissuedduringperiodsharesstockoptionsexercised": 602533,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 460599,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4964205,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 1.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2one": "P3Y2M16D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P2Y3M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 5304835,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 5.3,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 8.86,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 6.52,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 753000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 324742,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P9Y4M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 4964205,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 780500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 349315,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsoptionsremainingtobeissued": 3775852,
    "saleofstockpricepershare": 8.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1253390,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 80000000,
    "saleofstocknumberofsharesissuedintransaction": 2186855,
    "commissionsandprofessionalfees": 95778,
    "warrantsissuedtopurchasecommonstock": 780500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 8.86,
    "proceedsfromissuanceofwarrants": 678240,
    "totalnumbersofrepurchaseofwarrants": 349315,
    "repaymentsofrelatedpartydebt": 58334,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 100258,
    "proceedsfromwarrantexercises": 135400,
    "warrantstopurchasesharesofcommonstock": 200000,
    "investmentoptionsexerciseprice": 3.15,
    "descriptionofstockoptionsexercisableterm": "The stock options have terms of ten years and are subject to vesting based on continuous service of the awardee over a four-year period."
  }
]